CD8A and neoplasm: The lymphoid biomarker panel depicts CD3+ T cells, CD3+CD8+ cytotoxic T cells, and CD3+FOXP3+ regulatory T cells (Tregs), while the myeloid biomarker panel shows CD68+ macrophages; the tumor cells were stained for PanCK/SOX10.